Payment overview · 2025
General Payments
$364.68
18 reported records · 6 companies
Healthcare provider profile · identity verified
Scott B Arnett, MD
Allopathic & Osteopathic Physicians|Family Medicine · PRESTONSBURG, KY · NPI 1225134489
Verified facts
What the public records show
CMS Open Payments records show Scott B Arnett, MD received $364.68 in general payments during 2025 across 18 reported records.
ABBVIE INC. accounted for 53.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 63 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $193.56 | 53.1% | 9 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $44.58 | 12.2% | 3 | 2025 |
| SHIELD THERAPEUTICS INC | Unresolved — no canonical attribution shown | $42.32 | 11.6% | 2 | 2025 |
| Ardelyx, Inc. | Unresolved — no canonical attribution shown | $39.36 | 10.8% | 2 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $27.75 | 7.6% | 1 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $17.11 | 4.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $364.68 | 18 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $159.10 | 8 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $105.83 | 4 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $44.58 | 3 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $44.58 | 3 | 2025 |
Source payment records
|
|||||
| ACCRUFER Normalized: accrufer |
Drug | SHIELD THERAPEUTICS INC | $42.32 | 2 | 2025 |
Source payment records
|
|||||
| IBSRELA Normalized: ibsrela |
Drug | Ardelyx, Inc. | $39.36 | 2 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $27.75 | 1 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $17.11 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
63 | 11 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
37 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 710 | 153 |
| Atorvastatin Calcium | Atorvastatin Calcium | 665 | 125 |
| Gabapentin | Gabapentin | 626 | 98 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 615 | 109 |
| Levothyroxine Sodium | Levothyroxine Sodium | 539 | 101 |
| Pantoprazole Sodium | Pantoprazole Sodium | 463 | 95 |
| Omeprazole | Omeprazole | 378 | 70 |
| Lisinopril | Lisinopril | 377 | 81 |
| Metoprolol Succinate | Metoprolol Succinate | 374 | 72 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 340 | 85 |
| Potassium Chloride | Potassium Chloride | 327 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 300 | 68 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 298 | 62 |
| Losartan Potassium | Losartan Potassium | 272 | 53 |
| Irbesartan | Irbesartan | 250 | 54 |
| Furosemide | Furosemide | 244 | 52 |
| Jardiance | Empagliflozin | 237 | 35 |
| Metformin Hcl Er | Metformin Hcl | 237 | 47 |
| Clonazepam | Clonazepam | 208 | 31 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 202 | 36 |
| Valsartan | Valsartan | 202 | 47 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 195 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 195 | 35 |
| Tramadol Hcl | Tramadol Hcl | 192 | 34 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 188 | 44 |
| Famotidine | Famotidine | 185 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 177 | 47 |
| Eliquis | Apixaban | 169 | 30 |
| Montelukast Sodium | Montelukast Sodium | 167 | 29 |
| Diazepam | Diazepam | 158 | 25 |
| Metformin Hcl | Metformin Hcl | 156 | 33 |
| Mounjaro | Tirzepatide | 152 | 24 |
| Sucralfate | Sucralfate | 149 | 24 |
| Meloxicam | Meloxicam | 131 | 28 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 129 | 21 |
| Amitriptyline Hcl | Amitriptyline Hcl | 123 | 23 |
| Sertraline Hcl | Sertraline Hcl | 121 | 27 |
| Celecoxib | Celecoxib | 117 | 22 |
| Repatha Sureclick | Evolocumab | 117 | 24 |
| Finasteride | Finasteride | 114 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 113 | 31 |
| Alprazolam | Alprazolam | 112 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 110 | 23 |
| Carvedilol | Carvedilol | 109 | 26 |
| Pregabalin | Pregabalin | 103 | 17 |
| Ozempic | Semaglutide | 100 | 18 |
| Atenolol | Atenolol | 99 | 13 |
| Glipizide Er | Glipizide | 99 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 98 | 19 |
| Simvastatin | Simvastatin | 98 | 23 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 98 | 19 |
| Farxiga | Dapagliflozin Propanediol | 93 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 91 | 31 |
| Allopurinol | Allopurinol | 89 | 19 |
| Xarelto | Rivaroxaban | 86 | 12 |
| Lorazepam | Lorazepam | 85 | 12 |
| Trulicity | Dulaglutide | 77 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 76 | 15 |
| Ezetimibe | Ezetimibe | 72 | 21 |
| Doxazosin Mesylate | Doxazosin Mesylate | 70 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 70 | 14 |
| Alendronate Sodium | Alendronate Sodium | 69 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 69 | 14 |
| Donepezil Hcl | Donepezil Hcl | 67 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 67 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 67 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | 14 |
| Colestipol Hcl | Colestipol Hcl | 63 | suppressed |
| Linzess | Linaclotide | 63 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 60 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 59 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 58 | suppressed |
| Glipizide | Glipizide | 58 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 58 | 16 |
| Terazosin Hcl | Terazosin Hcl | 57 | 11 |
| Bupropion Xl | Bupropion Hcl | 56 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 56 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 53 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 51 | suppressed |
| Topiramate | Topiramate | 49 | 13 |
| Fenofibrate | Fenofibrate Nanocrystallized | 48 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 47 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 45 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 45 | 14 |
| Trazodone Hcl | Trazodone Hcl | 45 | suppressed |
| Azithromycin | Azithromycin | 41 | 36 |
| Prednisone | Prednisone | 41 | 33 |
| Spiriva Handihaler | Tiotropium Bromide | 41 | suppressed |
| Chlorthalidone | Chlorthalidone | 40 | suppressed |
| Gemfibrozil | Gemfibrozil | 40 | suppressed |
| Lansoprazole | Lansoprazole | 40 | suppressed |
| Ibuprofen | Ibuprofen | 39 | 11 |
| Methocarbamol | Methocarbamol | 39 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 39 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 38 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 37 | 33 |
| Synthroid | Levothyroxine Sodium | 37 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 37 | suppressed |
| Levetiracetam | Levetiracetam | 36 | suppressed |
| Ondansetron Odt | Ondansetron | 36 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 36 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 36 | suppressed |
| Erythromycin | Erythromycin Base | 35 | suppressed |
| Brilinta | Ticagrelor | 33 | suppressed |
| Fluconazole | Fluconazole | 32 | 18 |
| Clonidine Hcl | Clonidine Hcl | 31 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 31 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Januvia | Sitagliptin Phosphate | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 26 |
| Spironolactone | Spironolactone | 27 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 26 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 25 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Fentanyl | Fentanyl | 24 | suppressed |
| Ketoconazole | Ketoconazole | 24 | suppressed |
| Mesalamine | Mesalamine | 24 | suppressed |
| Mirtazapine | Mirtazapine | 24 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Ranolazine Er | Ranolazine | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Cefdinir | Cefdinir | 22 | 22 |
| Nystatin | Nystatin | 22 | 16 |
| Rivastigmine | Rivastigmine | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 21 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 21 | suppressed |
| Glyburide | Glyburide | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 19 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 16 |
| Cephalexin | Cephalexin | 18 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 18 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 18 | suppressed |
| Clonidine | Clonidine | 17 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Memantine Hcl | Memantine Hcl | 17 | suppressed |
| Pentoxifylline | Pentoxifylline | 17 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 17 | suppressed |
| Metronidazole | Metronidazole | 16 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 16 | suppressed |
| Premarin | Estrogens, Conjugated | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Constulose | Lactulose | 15 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Cimetidine | Cimetidine | 14 | suppressed |
| Felodipine Er | Felodipine | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 13 |
| Lidocaine | Lidocaine | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | 11 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 12 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Neupro | Rotigotine | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $364.68 · 18 records | ABBVIE INC. | ACCRUFER, Dexcom G6 Transmitter, IBSRELA, OTEZLA, QULIPTA, REPATHA, UBRELVY, ZENPEP | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error